These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24065803)

  • 1. Comment on: Selvin et al. sRAGE and risk of diabetes, cardiovascular disease, and death. Diabetes 2013;62:2116-2121.
    Schalkwijk CG; Stehouwer CD
    Diabetes; 2013 Oct; 62(10):e25. PubMed ID: 24065803
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: Selvin et al. sRAGE and risk of diabetes, cardiovascular disease, and death. Diabetes 2013;62:2116-2121.
    Yamagishi S
    Diabetes; 2013 Oct; 62(10):e26. PubMed ID: 24065804
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to comments on: Selvin et al. sRAGE and risk of diabetes, cardiovascular disease, and death. Diabetes 2013;62:2116-2121.
    Selvin E; Coresh J; Halushka MK
    Diabetes; 2013 Oct; 62(10):e27. PubMed ID: 24065805
    [No Abstract]   [Full Text] [Related]  

  • 4. sRAGE and risk of diabetes, cardiovascular disease, and death.
    Selvin E; Halushka MK; Rawlings AM; Hoogeveen RC; Ballantyne CM; Coresh J; Astor BC
    Diabetes; 2013 Jun; 62(6):2116-21. PubMed ID: 23396398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes.
    Thomas MC; Söderlund J; Lehto M; Mäkinen VP; Moran JL; Cooper ME; Forsblom C; Groop PH;
    Diabetologia; 2011 Oct; 54(10):2669-77. PubMed ID: 21607631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EnRAGEd about death in type 1 diabetes.
    Orchard TJ
    Diabetologia; 2011 Oct; 54(10):2480-2. PubMed ID: 21725840
    [No Abstract]   [Full Text] [Related]  

  • 7. Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes.
    Humpert PM; Djuric Z; Kopf S; Rudofsky G; Morcos M; Nawroth PP; Bierhaus A
    Cardiovasc Diabetol; 2007 Mar; 6():9. PubMed ID: 17343760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could receptors for advanced glycation end products be considered cardiovascular risk markers in obese children?
    de Giorgis T; D'Adamo E; Giannini C; Chiavaroli V; Scarinci A; Verrotti A; Chiarelli F; Mohn A
    Antioxid Redox Signal; 2012 Jul; 17(2):187-91. PubMed ID: 22315985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble receptor of advanced glycation end-products and endothelial dysfunction in COPD.
    Urban MH; Valipour A; Kiss D; Eickhoff P; Funk GC; Burghuber OC
    Respir Med; 2014 Jun; 108(6):891-7. PubMed ID: 24742363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes.
    Yamagishi S; Matsui T; Nakamura K
    Curr Drug Targets; 2007 Oct; 8(10):1138-43. PubMed ID: 17979674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of receptor for advanced glycation end products contributes to aortic remodeling and endothelial dysfunction in sinoaortic denervated rats.
    Wu F; Feng JZ; Qiu YH; Yu FB; Zhang JZ; Zhou W; Yu F; Wang GK; An LN; Ni FH; Wu H; Zhao XX; Qin YW; Luo HD
    Atherosclerosis; 2013 Aug; 229(2):287-94. PubMed ID: 23880178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease: what's all the AGE/RAGE about?
    Barlovic DP; Thomas MC; Jandeleit-Dahm K
    Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):7-15. PubMed ID: 20041839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study.
    Nin JW; Jorsal A; Ferreira I; Schalkwijk CG; Prins MH; Parving HH; Tarnow L; Rossing P; Stehouwer CD
    Diabetes; 2010 Aug; 59(8):2027-32. PubMed ID: 20522598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging.
    Yan SF; D'Agati V; Schmidt AM; Ramasamy R
    Curr Mol Med; 2007 Dec; 7(8):699-710. PubMed ID: 18331228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study.
    Nin JW; Ferreira I; Schalkwijk CG; Prins MH; Chaturvedi N; Fuller JH; Stehouwer CD;
    Diabetologia; 2009 Apr; 52(4):705-14. PubMed ID: 19183936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGCG-rich green tea extract stimulates sRAGE secretion to inhibit S100A12-RAGE axis through ADAM10-mediated ectodomain shedding of extracellular RAGE in type 2 diabetes.
    Huang SM; Chang YH; Chao YC; Lin JA; Wu CH; Lai CY; Chan KC; Tseng ST; Yen GC
    Mol Nutr Food Res; 2013 Dec; 57(12):2264-8. PubMed ID: 23901023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrafollicular soluble receptor for advanced glycation end products (sRAGE) and embryo quality in assisted reproduction.
    Bonetti TC; Borges E; Braga DP; Iaconelli A; Kleine JP; Silva ID
    Reprod Biomed Online; 2013 Jan; 26(1):62-7. PubMed ID: 23182743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population.
    Norata GD; Garlaschelli K; Grigore L; Tibolla G; Raselli S; Redaelli L; Buccianti G; Catapano AL
    Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):129-34. PubMed ID: 18595673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. sRAGE in diabetic and non-diabetic critically ill patients: effects of intensive insulin therapy.
    Arabi YM; Dehbi M; Rishu AH; Baturcam E; Kahoul SH; Brits RJ; Naidu B; Bouchama A
    Crit Care; 2011 Aug; 15(4):R203. PubMed ID: 21871056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.